RKL Wealth Management LLC Sells 3,345 Shares of Johnson & Johnson (NYSE:JNJ)

RKL Wealth Management LLC lowered its stake in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 10.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,680 shares of the company's stock after selling 3,345 shares during the quarter. RKL Wealth Management LLC's holdings in Johnson & Johnson were worth $4,590,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. Astoria Portfolio Advisors LLC. lifted its position in shares of Johnson & Johnson by 218.8% in the 1st quarter. Astoria Portfolio Advisors LLC. now owns 8,413 shares of the company's stock worth $1,307,000 after acquiring an additional 5,774 shares during the period. ABLE Financial Group LLC lifted its position in Johnson & Johnson by 2.7% in the first quarter. ABLE Financial Group LLC now owns 3,000 shares of the company's stock worth $498,000 after purchasing an additional 80 shares during the period. JNBA Financial Advisors boosted its stake in Johnson & Johnson by 1.0% during the first quarter. JNBA Financial Advisors now owns 10,287 shares of the company's stock worth $1,706,000 after buying an additional 100 shares in the last quarter. Kampmann Melissa S. increased its holdings in Johnson & Johnson by 11.9% in the 1st quarter. Kampmann Melissa S. now owns 22,354 shares of the company's stock valued at $3,707,000 after buying an additional 2,375 shares during the period. Finally, Heritage Investment Group Inc. raised its stake in shares of Johnson & Johnson by 3.7% in the 1st quarter. Heritage Investment Group Inc. now owns 4,519 shares of the company's stock valued at $749,000 after buying an additional 160 shares in the last quarter. 69.55% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

JNJ has been the topic of a number of analyst reports. Guggenheim reissued a "neutral" rating on shares of Johnson & Johnson in a research note on Wednesday, April 2nd. Sanford C. Bernstein reiterated a "market perform" rating on shares of Johnson & Johnson in a research note on Wednesday, April 16th. Barclays dropped their target price on Johnson & Johnson from $166.00 to $165.00 and set an "equal weight" rating for the company in a report on Thursday, April 17th. Raymond James Financial lowered their price target on Johnson & Johnson from $165.00 to $162.00 and set an "outperform" rating on the stock in a research report on Monday, April 14th. Finally, Benchmark raised Johnson & Johnson to a "strong-buy" rating in a report on Thursday, April 24th. Eleven analysts have rated the stock with a hold rating, seven have assigned a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $170.88.

Johnson & Johnson Trading Up 0.2%

Johnson & Johnson stock traded up $0.34 during mid-day trading on Thursday, hitting $155.90. The stock had a trading volume of 3,482,521 shares, compared to its average volume of 8,027,945. The stock has a 50-day simple moving average of $153.63 and a two-hundred day simple moving average of $153.88. The company has a current ratio of 1.26, a quick ratio of 1.03 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $375.11 billion, a PE ratio of 17.34, a P/E/G ratio of 2.36 and a beta of 0.41. Johnson & Johnson has a 12 month low of $140.68 and a 12 month high of $169.99.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last issued its earnings results on Tuesday, April 15th. The company reported $2.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.59 by $0.18. The company had revenue of $21.89 billion for the quarter, compared to analyst estimates of $21.65 billion. Johnson & Johnson had a net margin of 24.42% and a return on equity of 33.46%. As a group, sell-side analysts forecast that Johnson & Johnson will post 10.58 EPS for the current year.

Johnson & Johnson Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 10th. Stockholders of record on Tuesday, May 27th were paid a $1.30 dividend. The ex-dividend date was Tuesday, May 27th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 3.34%. This is an increase from Johnson & Johnson's previous quarterly dividend of $1.24. Johnson & Johnson's dividend payout ratio is 57.84%.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.